Skip to content
★ Sign in to follow
MF

Michael F. Brigham

Executive
Immucell Corp
Total declarations
14
Company
1
▲ Purchases (5 ops.)
€58k
▼ Sales (0 ops.)
—

Latest filing published 24 Mar 2026 for Immucell CORP, €126k.

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

Closed purchases

Market purchases
5
Positive at T+90
50%
Median T+90
-1.6%

Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 10 Dec 2010 · 5812 days ago · €1,510
    +58.3%
    Entry US$3.00 · Close at T+365 US$4.75
  • Filed 27 Feb 2009 · 6463 days ago · €53k
    +132.1%
    Entry US$1.68 · Close at T+365 US$3.90
  • Filed 03 Jan 2008 · 6884 days ago · €862
    -54.6%
    Entry US$3.66 · Close at T+365 US$1.66
  • Filed 26 Dec 2007 · 6892 days ago · €1,391
    -52.8%
    Entry US$3.71 · Close at T+365 US$1.75

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Michael F. Brigham: trading record in brief

Michael F. Brigham discloses dealings in Immucell Corp to SEC (Form 4). Over a trading history stretching from 28 March 2006 to 20 March 2026, the count stands at 14 filings.

On the market, this insider has only ever bought: 5 purchases, €58k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant and 6 option exercises.

A typical purchase (the median) is worth €1,391. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 50% of cases; the median change was -1.6%. This is a record of the past, not a forecast.

The latest filing, published on 24 March 2026, reports an option exercise of €126k in Immucell Corp. The last insider purchase was made public on 10 December 2010, 5,812 days ago. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Michael F. Brigham

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total
  • ◇
    DirectorExecutivesImmucell Corp
    146,000 USD16SEC
    25,000 shares@ US$5.840.15% mcap50.0% of flowCommon Stock, par value $.01 per shareSEC:0001437749-26-009661:0
  • ◆
    DirectorExecutivesImmucell Corp
    145,996 USD16SEC
    24,052 shares@ US$6.070.15% mcap50.0% of flowCommon Stock, par value $.01 per shareSEC:0001437749-26-009661:1
  • ◇
    President & CEOExecutivesImmucell Corp
    80,750 USD24SEC
    47,500 shares@ US$1.7021.9% of flowCommon Stock, par value $0.10 per shareSEC:0001213900-18-017963:0
  • ◇
    President & CEOExecutivesImmucell Corp
    5,250 USD22SEC
    1,000 shares@ US$5.251.5% of flowCommon Stock, par value $0.10 per shareSEC:0001547522-17-000042:0
  • ●
    President and CEOExecutivesImmucell Corp
    3,195 USD0SEC
    618 shares@ US$5.17Common StockSEC:0001144204-11-065617:0
  • ◇
    President and CEOExecutivesImmucell Corp
    3,200 USD0SEC
    1,000 shares@ US$3.20Common StockSEC:0001144204-11-065617:1
  • ▲
    President & CEOExecutivesImmucell Corp
    2,000 USD0SEC
    1,000 shares@ US$2.00Common Stock, par value $0.10 per shareSEC:0001181431-10-060714:0
    Canonical exit: 10 Mar 2011 (T+90)
  • ▲
    President & CEOExecutivesImmucell Corp
    66,810 USD0SEC
    51,000 shares@ US$1.31Common Stock, par value $0.10 per shareSEC:0001181431-09-011954:0
    Canonical exit: 28 May 2009 (T+90)
  • ▲
    President & CEOExecutivesImmucell Corp
    1,269 USD0SEC
    388 shares@ US$3.27Common stock, par value $0.10 per shareSEC:0001181431-08-000524:0
    Canonical exit: 1 Apr 2008 (T+90)
  • ▲
    President & CEOExecutivesImmucell Corp
    2,001 USD0SEC
    612 shares@ US$3.27Common stock, par value $0.10 per shareSEC:0001181431-07-077404:0
    Canonical exit: 18 Mar 2008 (T+90)

10 of 10 declarations